| Net income | 19.8M |
| Depreciation and amortization | 76.79M |
| Deferred income taxes | |
| Share-based compensation | 14.12M |
| Excess tax benefits from share-based compensation arrangements | -908K |
| Foreign currency translation gain | |
| Amortization of marketable securities premiums, net | |
| Membership fees receivable, net | 83.32M |
| Deferred incentive compensation | |
| Prepaid expenses and other current assets | |
| Other non-current assets | -8.69M |
| Accounts payable and accrued liabilities | -8.75M |
| Accrued incentive compensation | -14.83M |
| Deferred revenues | -47.85M |
| Other liabilities | 8.99M |
| Net cash flows provided by operating activities | |
| Purchases of property and equipment | -15.66M |
| Acquisition of business, net of cash acquired | -269.22M |
| Cost Method investment | |
| Maturities of marketable securities | |
| Net cash flows ( used in ) provided by investing activities | |
| Proceeds from the exercise of common stock options | |
| Proceeds from the issuance of common stock under the employee stock purchase plan | |
| Excess tax benefits from share-based compensation arrangements | 908K |
| Acquisition of business, contingent consideration | |
| Credit facility issuance costs | |
| Purchases of treasury shares | -53.57M |
| Payment of dividends | -39.92M |
| Net cash flows used in financing activities | |
| Effect of exchange rates on cash | -3.65M |
| Net increase in cash and cash equivalents | 22.49M |
| Cash and cash equivalents, beginning of period | 113.33M |
| Cash and cash equivalents, end of period | 135.82M |